calendar

2 catalysts · 11 grant · 3 8k filing · 2 earnings · 2 phase readout

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

hide past →

sort

soonest latest type sponsor alpha

matching 'CRISPR'×type: phase readout×clear all

type

grant11
8k filing3
earnings2
phase readout2

therapy area

no tagged catalysts yet

Date TBD

›

COMPLETED

phase readout

NCT06594094: An Open-label, Multidose Dose-escalation Study to Understand the Safety of CRISPR Gene-editing Therapy and Its Long-Lasting Effects in DMD Patients (MUSCLE)

Sponsor: HuidaGene Therapeutics Co., Ltd.. Phase: EARLY_PHASE1. Conditions: Duchenne Muscular Dystrophin (DMD)

full page →ctgov ↗

›COMPLETEDphase readoutNCT06492304: A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed/Refractory Hematologic Malignancies

Sponsor: CRISPR Therapeutics. Phase: PHASE1. Conditions: T Cell Lymphoma, B Cell Lymphoma, Acute Myeloid Leukemia

full page →ctgov ↗